| Biological Sciences | Lifetime | 208 | CA 7 | 99.97 |
| Biological Sciences | 2021-2025 | 70 | CA 4 | 99.94 |
| Genetics | Lifetime | 9 | CA 1 | 99.96 |
| Epidemiology | Lifetime | 172 | CA 9 | 99.78 |
| Immunology | Lifetime | 668 | CA 21 | 97.95 |
| Gastroenterology | Lifetime | 528 | CA 15 | 88.41 |
| Genetics | 2021-2025 | 8 | CA 1 | 99.89 |
| Epidemiology | 2021-2025 | 148 | CA 4 | 99.05 |
| Immunology | 2021-2025 | 231 | CA 6 | 94.72 |
| Surgery | 2021-2025 | 551 | CA 29 | 95.43 |
| Medical Genetics | 2021-2025 | 231 | CA 7 | 88.92 |
| Inflammatory Bowel Disease | Lifetime | 5 | CA 1 | 99.96 |
| Microscopic Colitis | Lifetime | 4 | CA 1 | 99.95 |
| Autoimmune and Inflammatory Disorders | Lifetime | 3 | CA 1 | 99.93 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 13 | CA 1 | 99.87 |
| Eosinophilic Esophagitis | Lifetime | 21 | CA 2 | 99.79 |
| Biosimilars and Bioanalytical Methods | Lifetime | 15 | CA 2 | 99.48 |
| Helicobacter pylori-related gastroenterology studies | Lifetime | 125 | CA 7 | 99.35 |
| Pregnancy and Medication Impact | Lifetime | 46 | CA 2 | 99.12 |
| Celiac Disease Research and Management | Lifetime | 42 | CA 1 | 98.99 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 289 | CA 25 | 99.13 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 331 | CA 9 | 99.04 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 215 | CA 16 | 98.56 |
| Liver Diseases and Immunity | Lifetime | 220 | CA 11 | 98.15 |
| Diagnosis and treatment of tuberculosis | Lifetime | 395 | CA 14 | 95.40 |
| Pharmacological Effects of Natural Compounds | Lifetime | 885 | CA 17 | 95.10 |
| Pharmaceutical studies and practices | Lifetime | 767 | CA 55 | 95.30 |
| Diverticular Disease and Complications | Lifetime | 589 | CA 26 | 95.50 |
| IL-33, ST2, and ILC Pathways | Lifetime | 871 | CA 35 | 92.81 |
| Whipple's Disease and Interleukins | Lifetime | 120 | CA 1 | 88.51 |
| Inflammatory Bowel Disease | 2021-2025 | 10 | CA 2 | 99.88 |
| Helicobacter pylori-related gastroenterology studies | 2021-2025 | 12 | CA 1 | 99.13 |
| Microscopic Colitis | 2021-2025 | 14 | CA 2 | 99.74 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 17 | CA 2 | 99.34 |
| Autoimmune and Inflammatory Disorders | 2021-2025 | 9 | CA 2 | 99.07 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 73 | CA 2 | 98.96 |
| Liver Diseases and Immunity | 2021-2025 | 47 | CA 3 | 98.15 |
| Eosinophilic Esophagitis | 2021-2025 | 104 | CA 9 | 97.46 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 447 | CA 22 | 90.58 |
| Celiac Disease Research and Management | 2021-2025 | 161 | CA 9 | 88.69 |
| Gastrointestinal Tumor Research and Treatment | 2021-2025 | 767 | CA 5 | 84.23 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 737 | CA 26 | 77.42 |
| Diverticular Disease and Complications | 2021-2025 | 687 | CA 28 | 76.03 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 580 | CA 9 | 73.44 |
